-
1
المؤلفون: Bozo Kruslin, Ivan Pavić, Josip Vlaić, Ana Tripalo Batoš, Ljiljana Zmak
المصدر: Joint Diseases and Related Surgery
مصطلحات موضوعية: Bursa, Synovial / surgery, medicine.medical_specialty, Tuberculosis, Bursitis, Adolescent, Fistula, Croatia, media_common.quotation_subject, Antitubercular Agents, Administration, Oral, Case Report, Thigh, Antituberculous drugs, Tuberculosis, Osteoarticular, surgery, Bursitis / drug therapy, anti-tuberculosis drugs, medicine, Humans, Orthopedics and Sports Medicine, Girl, Femur, Right Thigh, media_common, Tuberculosis, Osteoarticular / surgery, business.industry, Bursitis / surgery, General surgery, Rehabilitation, Tuberculosis, Osteoarticular / drug therapy, Antitubercular Agents / therapeutic use, Bursa, Synovial, medicine.disease, Tuberculosis, Osteoarticular / microbiology, tuberculous trochanteric bursitis, Tuberculosis, Osteoarticular / diagnosis, medicine.anatomical_structure, Hip Joint / surgery, Orthopedic surgery, Female, Hip Joint, adolescent, Bursitis / microbiology, business, Fistula / surgery, Femur / surgery
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5ae698f825489c795a4064bfc3aaac
http://europepmc.org/articles/PMC8343840 -
2
المؤلفون: Selidji Totagbe Agnandji, Bayode Romeo Adegbite, Arnaut Mfoumbi, Jeannot Fréjus Zinsou, Martin P. Grobusch, Yabo Josiane Honkpehedji, Chester Mevyann, Fabrice Lotola-Mougeni, Jean Ronald Edoa, Paulin Nndong Essone, Pacome Achimi Agbo, Ayola A. Adegnika, Micheska Epola, Jean Claude Dejon-Agobé, Mirabeau Mbong Ngwese, Peter G. Kremsner, Abraham Alabi
المساهمون: Graduate School, AII - Infectious diseases, APH - Global Health, APH - Aging & Later Life, Infectious diseases, APH - Quality of Care
المصدر: American journal of tropical medicine and hygiene, 103(6), 2501-2505. American Society of Tropical Medicine and Hygiene
Am J Trop Med Hygمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Tuberculosis, Adolescent, Cross-sectional study, medicine.medical_treatment, Antitubercular Agents/therapeutic use, 030231 tropical medicine, Antitubercular Agents, Logistic regression, Cigarette Smoking, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pulmonary/complications, Risk Factors, Virology, Internal medicine, Epidemiology, medicine, Odds Ratio, Humans, Gabon, Tuberculosis, Pulmonary, Gabon/epidemiology, Transmission (medicine), business.industry, Cigarette Smoking/adverse effects, Articles, Odds ratio, Middle Aged, medicine.disease, Tuberculosis, Pulmonary/complications, Infectious Diseases, Cross-Sectional Studies, Smoking cessation, Sputum, Parasitology, Female, medicine.symptom, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8115c64125a69647ea789548f01191e6
https://doi.org/10.4269/ajtmh.20-0424 -
3
المؤلفون: Leonor Almeida, António G. Castro, Angélica Ramos, Teresa Carvalho, Catarina Chaves, Nuno S. Osório, Fernando Rodrigues, Margarida Saraiva, João Tiago Guimarães, Leonor Meira, Rita Boaventura, Helder Novais Bastos, David Araújo
المساهمون: Instituto de Investigação e Inovação em Saúde, Universidade do Minho
المصدر: Pulmonology, Vol 25, Iss 6, Pp 320-327 (2019)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAPمصطلحات موضوعية: Male, Disseminated tuberculosis, Cirrhosis, medicine.medical_treatment, Antitubercular Agents, HIV Infections, Tuberculosis, Miliary / etiology, HIV Infections / complications, 0302 clinical medicine, Risk Factors, Weight loss, Odds Ratio, Culture conversion, Portugal / epidemiology, 030212 general & internal medicine, Antitubercular Agents / therapeutic use, Outcome, Smoking / epidemiology, Incidence (epidemiology), Smoking, Immunosuppression, Middle Aged, 3. Good health, Tuberculosis, Miliary / epidemiology, Cohort, Regression Analysis, Female, medicine.symptom, Adult, Pulmonary and Respiratory Medicine, Tuberculosis, Miliary / diagnosis, medicine.medical_specialty, Tuberculosis, Tuberculosis, Miliary / drug therapy, Statistics, Nonparametric, Immunocompromised Host, 03 medical and health sciences, Internal medicine, Statistical significance, medicine, Humans, Aged, Mycobacterium tuberculosis / isolation & purification, Retrospective Studies, lcsh:RC705-779, Science & Technology, Chi-Square Distribution, Portugal, Tuberculosis, Miliary, business.industry, Mycobacterium tuberculosis, lcsh:Diseases of the respiratory system, medicine.disease, 030228 respiratory system, business
وصف الملف: application/pdf
-
4
المؤلفون: Elena Sumarokova, Gina Gualano, Evgeny Belilovski, Armine Izadifar, Eva Tabernero, Pierre Bachez, Alessandro Torre, Maria Luiza de Souza-Galvão, François-Xavier Blanc, Claire Andrejak, Mathilde Fréchet Jachym, Denise Rossato Silva, Paolo Scarpellini, Margarita Marín Royo, Dina Visca, Ángel Domínguez-Castellano, Teresa Rodrigo, Antoine Froissart, Damien Le Dû, Giovanni Sotgiu, Antonio Spanevello, Pierre-Alexandre Bart, Simon Tiberi, Miguel Zabaleta Murguiondo, Frédéric Schlemmer, Marina Tadolini, Rosella Centis, Matteo Saporiti, Sergey Borisov, Giovanni Battista Migliori, Vania Giacomet, Delia Goletti, Frédéric Rivière, Ilaria Motta, Samir Dourmane, Soazic Grard, José Cardoso-Landivar, José-María García-García, Jesica Mazza-Stalder, Fabrizio Palmieri, Luigi Codecasa, Catherine W.M. Ong, Adrián Sánchez-Montalvá, Lia D'Ambrosio, Jan-Willem C. Alffenaar, Paul A. Tambyah
المساهمون: Tadolini M., Codecasa L.R., Garcia-Garcia J.-M., Blanc F.-X., Borisov S., Alffenaar J.-W., Andrejak C., Bachez P., Bart P.-A., Belilovski E., Cardoso-Landivar J., Centis R., D'Ambrosio L., De Souza-Galvao M.-L., Dominguez-Castellano A., Dourmane S., Jachym M.F., Froissart A., Giacomet V., Goletti D., Grard S., Gualano G., Izadifar A., Le Du D., Royo M.M., Mazza-Stalder J., Motta I., Min Ong C.W., Palmieri F., Riviere F., Rodrigo T., Silva D.R., Sanchez-Montalva A., Saporiti M., Scarpellini P., Schlemmer F., Spanevello A., Sumarokova E., Tabernero E., Tambyah P.A., Tiberi S., Torre A., Visca D., Murguiondo M.Z., Sotgiu G., Migliori G.B., Centre hospitalier universitaire de Nantes (CHU Nantes), University Medical Center Groningen [Groningen] (UMCG), CHU Amiens-Picardie, Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, CHU Henri Mondor, Centre Hospitalier Intercommunal de Créteil (CHIC), Istituto Nazionale di Malattie Infettive 'Lazzaro Spallanzani' (INMI), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Hôpital Raymond Poincaré [AP-HP], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Maturation des proteines, destinée cellulaire et thérapeutique (PROMTI), Département Biologie des Génomes (DBG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Aristotle University of Thessaloniki, [Tadolini,m] Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. [Codecasa,LR, Saporiti,M] TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy. [García-García,JM, Rodrigo,T]Tuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain. [Blanc,FX] Centre Hospitalier Universitaire, Nantes, France. [Borisov,S, Belilovski,E, Sumarokova,E] Moscow Research and Clinical Center for TB Control, Moscow, Russian Federation. [Alffenaar,JW] The University of Sydney, Sydney Pharmacy School, Sydney, Australia. [Alffenaar,JW] Westmead Hospital, Sydney, Australia. [Alffenaar,JW] Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia. [Andréjak,C] Service de Pneumologie CHU AMIENS PICARDIE, France AND UR Université de Picardie Jules Verne, Amiens, France. [Bachez,P] Service de Pneumologie, Clinique Saint Luc, Bouge, Belgium. [Bart,PA] Dept of Internal Medicine, Lausanne University, Lausanne, Switzerland. [Cardoso-Landivar,J] Servicio Neumología, Vall D´Hebron University Hospital, Barcelona, Spain. [Centis,R] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy. [D'Ambrosio,L] Public Health Consulting Group, Lugano, Switzerland. [Dominguez-Castellano,A] Servicio de Enfermedades Infecciosas y Microbiología, Hospital Virgen Macarena, Sevilla, Spain. [Dourmane,S] Service de Pneumologie, Groupe hospitalier sud île de France (GHSIF), Melun, France. [Fréchet Jachym,M, Le Du,D] Centre Hospitalier de Bligny, Briis Sous Forges, France. [Froissart,A] Service de Médecine interne, CHI de Créteil, Créteil, France. [Giacomet,V]20Pediatric Infectious Diseases Unit, Dept of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy. [Goletti,D] Translational Research Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Grard,S] Centre de Lutte Antituberculeuse (CLAT 38), Grenoble, France. [Gualano,G, Palmieri,F] Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Izadifar,A] Hôpital Européen de Paris La Roseraie, Aubervilliers, France. [Marín Royo,M] Servicio Neumología, Hospital General Universitario de Castellón, Castelló, Spain. [Mazza-Stalder,J] Pulmonary Division, Lausanne University Hospital CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Motta,I] Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italia. [Ong,CWM, Tambyah,PA] Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [Ong,CWM, Tambyah,PA] Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore. [Rivière,F] Hôpital d'Instruction des Armées (HIA) Percy, Clamart, France. [Silva,DR] Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS, Porto Alegre, Brazil. [Sánchez-Montalvá,A]Infectious Diseases Dept, International Health and Tuberculosis Unit, Vall d'Hebron University Hospital, Barcelona, Spain. [Sánchez-Montalvá,A] Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain. [Sánchez-Montalvá,A] Grupo de Estudio de Infecciones por Micobacterias (GEIM), Spanish Society of Infectious Diseases (SEIMC), Spain. [Scarpellini,P] Unit of Infectious Diseases, Università Vita e Salute, San Raffaele Hospital, Milan, Italy. [Schlemmer,F] Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France. [Spanevello,A, Visca,D] Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy. [Spanevello,A, Visca,D] Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Italy. [Tabernero,E] Servicio Neumología, Hospital de Cruces, Bilbao, Spain. [Tiberi,S] Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. [Tiberi,S] Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. [Torre,A] Dept of Infectious Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. [Zabaleta Murguiondo,M] Servicio Neumología Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Sotgiu,G] Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. [Migliori,GB] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy., CHU Henri Mondor [Créteil]
المصدر: The European Respiratory Journal
article-version (AM) Accepted Manuscript
The European respiratory journal, vol. 56, no. 1
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
European Respiratory Journal, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩مصطلحات موضوعية: Male, Pediatrics, Adult, Aged, Antitubercular Agents/therapeutic use, Antiviral Agents/therapeutic use, Azithromycin/therapeutic use, Betacoronavirus, Clinical Laboratory Techniques, Cohort Studies, Coinfection, Coronavirus Infections/complications, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Drug Combinations, Emigrants and Immigrants, Female, Humans, Hydroxychloroquine/therapeutic use, Lopinavir/therapeutic use, Lung/diagnostic imaging, Middle Aged, Mortality, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Ritonavir/therapeutic use, Tomography, X-Ray Computed, Tuberculosis/complications, Tuberculosis/diagnosis, Tuberculosis/drug therapy, Tuberculosis, Pulmonary/complications, Tuberculosis, Pulmonary/diagnosis, Tuberculosis, Pulmonary/drug therapy, [SDV]Life Sciences [q-bio], viruses, Antitubercular Agents, Azithromycin, Clinical Laboratory Technique, Lopinavir, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Sequelae, Antitubercular Agent, 0302 clinical medicine, COVID-19 Testing, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography [Medical Subject Headings], Drug Combination, 030212 general & internal medicine, Viral, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques [Medical Subject Headings], Lung, Tomography, ComputingMilieux_MISCELLANEOUS, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Vital Statistics::Mortality [Medical Subject Headings], virus diseases, Pulmonary, respiratory system, X-Ray Computed, Impactos en la salud, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography [Medical Subject Headings], Cohort, Coronavirus Infections, medicine.drug, Cohort study, Human, Hydroxychloroquine, Impacts on health, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Tuberculosis, Tuberculosi, Infecciones por coronavirus, Estudios de cohortes, Pneumonia, Viral, Antiviral Agents, Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Mycobacterium Infections::Tuberculosis [Medical Subject Headings], 03 medical and health sciences, Tuberculosis diagnosis, medicine, Research Letter, Tuberculosis, Pulmonary, Secuelas, Ritonavir, Antiviral Agent, Pandemia, Betacoronaviru, Pandemic, business.industry, Coronavirus Infection, SARS-CoV-2, COVID-19, Emigrants and Immigrant, Pneumonia, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents::Antitubercular Agents [Medical Subject Headings], medicine.disease, Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [Medical Subject Headings], COVID-19 Drug Treatment, Coronavirus, 030228 respiratory system, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Cohort Studie, business
وصف الملف: ELETTRONICO; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe58fdd4efa3f56b2737cc2d5e084a8
http://hdl.handle.net/11383/2095863 -
5
المؤلفون: Govinda Prasad Dhungana, Wei Hong Zhang, Usha Bhatta, Pruthu Thekkur, Palanivel Chinnakali, Basudev Pandey
المصدر: BMJ open, 9 (5
BMJ Open
BMJ OPENمصطلحات موضوعية: Male, HIV Infections -- complications, Antitubercular Agents, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, infectious diseases, 0302 clinical medicine, ANTIRETROVIRAL THERAPY, Completion rate, Medicine and Health Sciences, IMPLEMENTATION, 030212 general & internal medicine, PREDICTORS, Child, INFECTED PATIENTS, Public health, Isoniazid, General Medicine, Middle Aged, Preventive therapy, Child, Preschool, CASE NOTIFICATION RATES, Quality in health care, HIV/AIDS, Female, medicine.drug, Adult, medicine.medical_specialty, Tuberculosis, Adolescent, health services administration & management, TUBERCULOSIS INCIDENCE, 030231 tropical medicine, SCALE-UP, Tuberculosis -- complications -- prevention & control, Medication Adherence, 03 medical and health sciences, Young Adult, primary care, ADHERENCE, Age Distribution, Nepal, parasitic diseases, medicine, Antitubercular Agents -- therapeutic use, Humans, Aged, Retrospective Studies, Droit, business.industry, Research, Infant, Newborn, Infant, Retrospective cohort study, ADULTS, medicine.disease, PILOT PROGRAM, Relative risk, Family medicine, Isoniazid -- therapeutic use, business
وصف الملف: 1 full-text file(s): application/pdf; application/pdf
-
6
المؤلفون: Barbara Rusch, Gugu Mchunu, Maryline Bonnet, Yolanda Mueller, Bernhard Kerschberger, Qhubekani Mpala, Sikhathele Mazibuko
المصدر: Medicine, vol. 96, no. 35, pp. e7740
مصطلحات موضوعية: 0301 basic medicine, Pediatrics, medicine.medical_specialty, Tuberculosis, Adult, Antitubercular Agents/administration & dosage, Antitubercular Agents/therapeutic use, Cohort Studies, Drug Administration Schedule, Feasibility Studies, Female, HIV Infections, Humans, Isoniazid/administration & dosage, Isoniazid/therapeutic use, Male, Medication Adherence, Middle Aged, Prospective Studies, Rural Health Services, Swaziland, Treatment Outcome, Tuberculosis, Pulmonary/mortality, Tuberculosis, Pulmonary/prevention & control, 03 medical and health sciences, 0302 clinical medicine, isoniazid preventive therapy, parasitic diseases, Medicine, 030212 general & internal medicine, adherence, Prospective cohort study, Contraindication, business.industry, Incidence (epidemiology), Isoniazid, General Medicine, medicine.disease, 030112 virology, Clinical trial, Tolerability, TB-HIV, business, Cohort study, medicine.drug
وصف الملف: application/pdf; text/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231178e4b5b56b099f1b50f35d9a3e4b
https://serval.unil.ch/notice/serval:BIB_8267A816FDAB -
7
المؤلفون: Julia Ríos, A. De Orbegoso, T. Párraga, P. Van der Stuyft, Carlos Seas, A. F. Navarro, Larissa Otero, Eduardo Gotuzzo
المصدر: Tropical Medicine & International Health. 20:322-325
مصطلحات موضوعية: Male, Time Factors, time to treatment, Antitubercular Agents, multirresistente, Outcome Assessment, Health Care, Peru, Tuberculosis, Multidrug-Resistant, biology, Drug Substitution, Incidence, Incidence (epidemiology), Infectious Diseases, tuberculosis, Female, purl.org/pe-repo/ocde/ford#3.03.06 [https], Perou, Adult, medicine.medical_specialty, Tuberculosis, Antitubercular Agents/therapeutic use, tuberculose, Time to treatment, Article, Mycobacterium tuberculosis, Outcome Assessment (Health Care), Internal medicine, medicine, Humans, Tuberculosis, Pulmonary, Retrospective Studies, business.industry, multidrug resistant, Tiempo hasta el inicio del tratamiento, Public Health, Environmental and Occupational Health, Retrospective cohort study, biology.organism_classification, medicine.disease, temps jusqu'au traitement, Tuberculosis, Pulmonary/drug therapy/epidemiology, Drug Substitution/statistics & numerical data, Surgery, Multiple drug resistance, Regimen, Tuberculosis, Multidrug-Resistant/drug therapy/epidemiology, Parasitology, multiresistante, business, Peru/epidemiology, Tb treatment
-
8
المؤلفون: Daniel Scott-Algara, Yoann Madec, Didier Laureillard, Polidy Pean, François-Xavier Blanc, Janin Nouhin, Céline Didier, Mathieu F. Chevalier, Laurence Weiss, Laurence Borand
المساهمون: VIH/Hépatites, Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université Paris Diderot - Paris 7 (UPD7), Immunologie [Phnom Penh], Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), Régulation des Infections Rétrovirales, Institut Pasteur [Paris], Unité d'Épidémiologie et de Santé Publique [Phnom Penh], Centre hospitalier universitaire de Nantes (CHU Nantes), Service des maladies infectieuses et tropicales, Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Sorbonne Paris Cité (USPC), This work was supported by ARI (Association pour la Recherche en Immunopathologie)., We thank all the patients who participated in the study. We also thank the ANRS for authorizing us to use the biobank of CAMELIA and CAPRI-NK for this work., Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Institut Pasteur [Paris] (IP)
المصدر: Journal of Infection
Journal of Infection, WB Saunders, 2017, 74 (5), pp.456-465. ⟨10.1016/j.jinf.2017.01.016⟩
Journal of Infection, 2017, 74 (5), pp.456-465. ⟨10.1016/j.jinf.2017.01.016⟩مصطلحات موضوعية: 0301 basic medicine, Male, Multivariate analysis, MESH: Immune Reconstitution Inflammatory Syndrome*/complications, MESH: Immune Reconstitution Inflammatory Syndrome*/blood, MESH: Biomarkers/blood, [SDV]Life Sciences [q-bio], MESH: Tuberculosis*/complications, Antitubercular Agents, HIV Infections, urologic and male genital diseases, MESH: Tuberculosis*/blood, 0302 clinical medicine, Immune Reconstitution Inflammatory Syndrome, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Macrophage, 030212 general & internal medicine, Randomized Controlled Trials as Topic, MESH: Case-Control Studies, female genital diseases and pregnancy complications, 3. Good health, TB-IRIS, Infectious Diseases, medicine.anatomical_structure, MESH: Tuberculosis*/drug therapy, Biomarker (medicine), Female, Fresh frozen plasma, Cambodia, MESH: Immune Reconstitution Inflammatory Syndrome*/diagnosis, Microbiology (medical), Adult, IL-1 receptor antagonist, MESH: Tuberculosis*/diagnosis, 03 medical and health sciences, Immune reconstitution inflammatory syndrome, medicine, Humans, Tuberculosis, Anti-tuberculosis treatment, cardiovascular diseases, HIV/tuberculosis co-infection, MESH: Humans, MESH: HIV Infections/complications, business.industry, urogenital system, Monocyte, fungi, MESH: Adult, medicine.disease, MESH: Antitubercular Agents/therapeutic use, MESH: Male, Interleukin 1 Receptor Antagonist Protein, 030104 developmental biology, Interleukin 1 receptor antagonist, MESH: Randomized Controlled Trials as Topic, Case-Control Studies, Immunology, MESH: Interleukin 1 Receptor Antagonist Protein/blood, business, Tb treatment, MESH: Female, Biomarkers
-
9
المؤلفون: Proano, Alvaro, Bravard, Marjory A., Lopez, Jose W., Lee, Gwenyth O., Bui, David, Datta, Sumona, Comina, German, Zimic-Peralta, Mirko Juan, Coronel, Jorge, Caviedes, Luz, Cabrera, Jose L., Salas, Antonio, Ticona, Eduardo, Vu, Nancy M., Kirwan, Daniela E., Loader, Maria-Cristina I., Friedland, Jon S., Moore, David Alexander James, Evans, Carlton Anthony William, Tracey, Brian H., Gilman, Robert Hugh
المصدر: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
مصطلحات موضوعية: Adult, Male, Adolescent, Antitubercular Agents/therapeutic use, Antitubercular Agents, purl.org/pe-repo/ocde/ford#3.03.08 [https], Microbiology, Young Adult, Cough/pathology, cough, Peru, Major Article, Humans, airborne transmission, infectiousness, Longitudinal Studies, Prospective Studies, Tuberculosis, Pulmonary, Aged, Aged, 80 and over, Tuberculosis, Pulmonary/drug therapy/pathology, 11 Medical And Health Sciences, Middle Aged, 06 Biological Sciences, Circadian Rhythm, respiratory tract diseases, Editor's Choice, tuberculosis, Female
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::42d27d53966ad7e9c0011777921a23b9
http://hdl.handle.net/10044/1/43820 -
10
المؤلفون: Timothy R. Sterling, Leonela Villegas, Moises A. Huaman, Larissa Otero, Carlos Seas, Eduardo Gotuzzo, Patrick Van der Stuyft
المصدر: PLoS ONE, Vol 11, Iss 4, p e0152933 (2016)
PLOS ONE
PLoS ONEمصطلحات موضوعية: Bacterial Diseases, RNA viruses, Male, 0301 basic medicine, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, lcsh:Medicine, Drug resistance, Pathology and Laboratory Medicine, 0302 clinical medicine, Immunodeficiency Viruses, Risk Factors, Peru, Prevalence, Medicine and Health Sciences, polycyclic compounds, 030212 general & internal medicine, lcsh:Science, Multidisciplinary, biology, Multi-Drug-Resistant Tuberculosis, Multi-drug-resistant tuberculosis, Isoniazid, Drugs, Infectious Diseases, Medical Microbiology, Behavioral Pharmacology, Viral Pathogens, Viruses, Tuberculosis Diagnosis and Management, Female, Rifampin/therapeutic use, Pathogens, Rifampin, Research Article, medicine.drug, Adult, medicine.medical_specialty, Tuberculosis, Isoniazid/therapeutic use, Antitubercular Agents/therapeutic use, 030106 microbiology, UNITED-STATES, Microbiology, Mycobacterium tuberculosis, 03 medical and health sciences, Antibiotic resistance, Diagnostic Medicine, Recreational Drug Use, Microbial Control, Internal medicine, Retroviruses, Drug Resistance, Bacterial, medicine, Humans, purl.org/pe-repo/ocde/ford#3.01.05 [https], Microbial Pathogens, Tuberculosis, Pulmonary, Pharmacology, DRUG-RESISTANCE, business.industry, Lentivirus, lcsh:R, Organisms, HIV, Biology and Life Sciences, Extensively drug-resistant tuberculosis, Tropical Diseases, bacterial infections and mycoses, medicine.disease, biology.organism_classification, Tuberculosis, Pulmonary/drug therapy/epidemiology, purl.org/pe-repo/ocde/ford#3.02.07 [https], MONORESISTANT TUBERCULOSIS, Immunology, lcsh:Q, Antimicrobial Resistance, business, Peru/epidemiology, Rifampicin
وصف الملف: application/pdf
Full Text via ClinicalKey